嘉华股份(603182) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was CNY 463,772,786.86, representing a year-on-year increase of 20.29%[5] - The net profit attributable to shareholders decreased by 13.17% to CNY 30,954,958.83 compared to the same period last year[5] - The basic earnings per share (EPS) fell by 34.48% to CNY 0.19 due to a decline in net profit and an increase in the number of shares[6] - In Q1 2023, total revenue was CNY 358.03 million, a decrease of 7.5% compared to CNY 384.90 million in Q1 2022[14] - Operating profit for Q1 2023 was ¥41,884,070.22, down 10.4% from ¥46,955,434.69 in Q1 2022[26] - Net profit for Q1 2023 was ¥30,954,958.83, a decrease of 13.5% compared to ¥35,649,692.14 in Q1 2022[26] - Basic and diluted earnings per share for Q1 2023 were both ¥0.19, down from ¥0.29 in Q1 2022[27] Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -49,435,449.45, primarily due to increased accounts receivable and timely settlement of payables[9] - Cash flow from operating activities showed a net outflow of ¥49,435,449.45 in Q1 2023, compared to a net outflow of ¥12,019,433.53 in Q1 2022[28] - Cash flow from investing activities resulted in a net outflow of ¥9,325,195.81 in Q1 2023, compared to a net outflow of ¥27,234,911.69 in Q1 2022[29] - Cash flow from financing activities generated a net inflow of ¥59,840,819.45 in Q1 2023, contrasting with a net outflow of ¥1,014,637.48 in Q1 2022[29] - Total assets at the end of the reporting period were CNY 1,268,272,832.70, an increase of 7.17% from the end of the previous year[6] - Total assets reached CNY 1.27 billion, up from CNY 1.18 billion at the end of 2022[23] - The total assets and shareholders' equity as of the end of Q1 2023 were ¥1,268,272,832.70 and ¥998,754,374.59 respectively, compared to ¥1,183,475,624.03 and ¥965,759,768.29 at the end of Q1 2022[25] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 15,239[10] - The top shareholder, Wu Hongxiang, holds 17.63% of the shares, totaling 29,004,322 shares[12] Sales and Market Performance - Soy protein sales accounted for 66.40% of total revenue, while soybean oil sales decreased to 17.32% from 19.25% year-over-year[14] - Direct sales increased to CNY 220.76 million, representing 61.49% of total sales, up from 53.58% in the same period last year[16] - Domestic sales were CNY 230.55 million, making up 64.21% of total sales, compared to 60.88% in Q1 2022[17] - The number of domestic distributors increased by 9 to 75, while the number of overseas distributors rose by 6 to 78[19] - The company reported a significant increase in sales revenue, indicating potential market expansion strategies[25] Research and Development - The company is focusing on research and development, with R&D expenses amounting to ¥3,014,184.90 in Q1 2023[26] Other Financial Metrics - The weighted average return on equity (ROE) decreased by 4.19 percentage points to 3.15%[6] - The company reported non-recurring gains and losses totaling CNY 952,359.77 for the period[8] - Cash and cash equivalents as of March 31, 2023, were CNY 435 million, slightly down from CNY 437 million at the end of 2022[22] - Accounts receivable increased significantly to CNY 159.05 million from CNY 74.89 million year-over-year[22] - Total liabilities increased to CNY 269.52 million from CNY 217.72 million year-over-year[24] - The company's retained earnings rose to CNY 407.04 million, compared to CNY 376.09 million at the end of 2022[24] - The company did not conduct an audit for the Q1 financial report[4]